Annual Operating Profit
-$222.61 M
-$54.73 M-32.60%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual operaing income is currently -$222.61 million, with the most recent change of -$54.73 million (-32.60%) on 31 December 2023. During the last 3 years, it has fallen by -$114.91 million (-106.69%). CRNX annual operating profit is now -3583.12% below its all-time high of -$6.04 million, reached on 31 December 2016.CRNX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$87.80 M
-$5.01 M-6.06%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly operating income is currently -$87.80 million, with the most recent change of -$5.01 million (-6.06%) on 30 September 2024. Over the past year, it has dropped by -$25.14 million (-40.12%). CRNX quarterly operating profit is now -5243.70% below its all-time high of -$1.64 million, reached on 30 June 2017.CRNX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$306.77 M
-$28.82 M-10.37%
30 September 2024
Summary:
Crinetics Pharmaceuticals TTM operating income is currently -$306.77 million, with the most recent change of -$28.82 million (-10.37%) on 30 September 2024. Over the past year, it has dropped by -$84.16 million (-37.81%). CRNX TTM operating profit is now -11658.03% below its all-time high of -$2.61 million, reached on 31 March 2017.CRNX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -40.1% | -37.8% |
| 3 y3 years | -106.7% | -184.2% | -184.8% |
| 5 y5 years | -313.5% | -477.1% | -469.9% |
CRNX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -106.7% | at low | -184.2% | at low | -184.8% | at low |
| 5 y | 5 years | -313.5% | at low | -477.1% | at low | -469.9% | at low |
| alltime | all time | -3583.1% | at low | -5243.7% | at low | <-9999.0% | at low |
Crinetics Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$87.80 M(+6.1%) | -$306.77 M(+10.4%) |
| June 2024 | - | -$82.78 M(+12.6%) | -$277.95 M(+12.0%) |
| Mar 2024 | - | -$73.53 M(+17.3%) | -$248.16 M(+11.5%) |
| Dec 2023 | -$222.61 M(+32.6%) | -$62.66 M(+6.2%) | -$222.61 M(+7.3%) |
| Sept 2023 | - | -$58.98 M(+11.3%) | -$207.51 M(+8.1%) |
| June 2023 | - | -$52.99 M(+10.5%) | -$191.98 M(+5.5%) |
| Mar 2023 | - | -$47.98 M(+0.9%) | -$182.03 M(+8.4%) |
| Dec 2022 | -$167.88 M(+55.9%) | -$47.56 M(+9.4%) | -$167.88 M(+11.0%) |
| Sept 2022 | - | -$43.45 M(+1.0%) | -$151.21 M(+11.5%) |
| June 2022 | - | -$43.05 M(+27.3%) | -$135.57 M(+14.3%) |
| Mar 2022 | - | -$33.83 M(+9.5%) | -$118.61 M(+10.1%) |
| Dec 2021 | -$107.70 M(+43.7%) | -$30.89 M(+11.1%) | -$107.70 M(+9.2%) |
| Sept 2021 | - | -$27.81 M(+6.6%) | -$98.61 M(+10.5%) |
| June 2021 | - | -$26.09 M(+13.8%) | -$89.25 M(+11.4%) |
| Mar 2021 | - | -$22.92 M(+5.2%) | -$80.09 M(+6.9%) |
| Dec 2020 | -$74.95 M | -$21.79 M(+18.1%) | -$74.95 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$18.45 M(+9.0%) | -$68.38 M(+4.9%) |
| June 2020 | - | -$16.93 M(-4.8%) | -$65.15 M(+5.8%) |
| Mar 2020 | - | -$17.78 M(+16.9%) | -$61.57 M(+14.4%) |
| Dec 2019 | -$53.83 M(+87.5%) | -$15.21 M(-0.1%) | -$53.83 M(+12.0%) |
| Sept 2019 | - | -$15.23 M(+14.1%) | -$48.05 M(+17.5%) |
| June 2019 | - | -$13.35 M(+32.9%) | -$40.89 M(+23.1%) |
| Mar 2019 | - | -$10.04 M(+6.5%) | -$33.23 M(+15.7%) |
| Dec 2018 | -$28.71 M(+214.6%) | -$9.43 M(+16.9%) | -$28.71 M(+31.8%) |
| Sept 2018 | - | -$8.07 M(+42.0%) | -$21.78 M(+35.4%) |
| June 2018 | - | -$5.68 M(+2.8%) | -$16.08 M(+33.5%) |
| Mar 2018 | - | -$5.53 M(+121.0%) | -$12.04 M(+32.0%) |
| Dec 2017 | -$9.13 M(+51.0%) | -$2.50 M(+5.3%) | -$9.13 M(+37.7%) |
| Sept 2017 | - | -$2.37 M(+44.5%) | -$6.63 M(+55.8%) |
| June 2017 | - | -$1.64 M(-37.0%) | -$4.25 M(+63.0%) |
| Mar 2017 | - | -$2.61 M | -$2.61 M |
| Dec 2016 | -$6.04 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly operating profit year-on-year change?
- What is Crinetics Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM operating profit year-on-year change?
What is Crinetics Pharmaceuticals annual operaing income?
The current annual operating profit of CRNX is -$222.61 M
What is the all time high annual operating profit for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual operaing income is -$6.04 M
What is Crinetics Pharmaceuticals quarterly operating income?
The current quarterly operating profit of CRNX is -$87.80 M
What is the all time high quarterly operating profit for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly operating income is -$1.64 M
What is Crinetics Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, CRNX quarterly operating income has changed by -$25.14 M (-40.12%)
What is Crinetics Pharmaceuticals TTM operating income?
The current TTM operating profit of CRNX is -$306.77 M
What is the all time high TTM operating profit for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM operating income is -$2.61 M
What is Crinetics Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, CRNX TTM operating income has changed by -$84.16 M (-37.81%)